{{Rsnum
|rsid=664677
|Gene=ATM
|Chromosome=11
|position=108272455
|Orientation=plus
|GMAF=0.3875
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(C;C)
|geno2=(C;T)
|geno3=(T;T)
|Gene_s=ATM
}}{{ population diversity
| geno1=(C;C)
| geno2=(C;T)
| geno3=(T;T)
| CEU | 19.5 | 53.1 | 27.4
| HCB | 35.8 | 43.8 | 20.4
| JPT | 41.6 | 40.7 | 17.7
| YRI | 2.7 | 35.4 | 61.9
| ASW | 5.3 | 26.3 | 68.4
| CHB | 35.8 | 43.8 | 20.4
| CHD | 32.1 | 49.5 | 18.3
| GIH | 9.9 | 38.6 | 51.5
| LWK | 5.5 | 39.1 | 55.5
| MEX | 20.7 | 43.1 | 36.2
| MKK | 14.7 | 53.8 | 31.4
| TSI | 11.8 | 33.3 | 54.9
| HapMapRevision=28
}}{{PMID Auto
|PMID=19286843
|Title=Polymorphisms of DNA damage response genes in radiation-related and sporadic papillary thyroid carcinoma
}}

{{PMID Auto
|PMID=21058196
|Title=Antioxidant vitamins intake, ataxia telangiectasia mutated (ATM) genetic polymorphisms, and breast cancer risk
}}

{{PMID Auto
|PMID=22203481
|Title=Association between ATM polymorphisms and cancer risk: a meta-analysis
}}

{{PMID|12466288|OA=1
}} Haplotype and linkage disequilibrium architecture for human cancer-associated genes.

{{PMID|16091150|OA=1
}} Characterization of the linkage disequilibrium structure and identification of tagging-SNPs in five DNA repair genes.

{{PMID|19536092|OA=1
}} Explorative study to identify novel candidate genes related to oxaliplatin efficacy and toxicity using a DNA repair array.

{{PMID|20004998}} ATM polymorphisms and risk of lung cancer among never smokers.

{{PMID Auto
|PMID=23925578
|Title=Association of the ATM gene polymorphisms with papillary thyroid cancer
}}

{{PMID Auto
|PMID=25196645
|Title=Single nucleotide polymorphisms of ataxia telangiectasia mutated and the risk of papillary thyroid carcinoma
}}
{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | Illumina Human 1M}}